journal article·2025-01Open access

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β‐Klotho‐Mediated Ferroptosis Inhibition

Shasha Tian, Saijun Zhou, Weixi Wu, Yao lin, Tongdan Wang, Haizhen Sun, A‐Shan‐Jiang A‐Ni‐Wan, Yaru Li, Chongyang Wang, Xiaogang Li, Pei Yu, Yanjun Zhao

Advanced Science· Volume 12· Issue 4

Abstract

Abstract Semaglutide (Smg), a GLP‐1 receptor agonist (GLP‐1RA), shows renal protective effects in patients with diabetic kidney disease (DKD). However, the exact underlying mechanism remains elusive. This study employs transcriptome sequencing and identifies β‐Klotho (KLB) as the critical target responsible for the role of Smg in kidney protection. Smg treatment alleviates diabetic kidney injury by inhibiting ferroptosis in patients, animal models, and HK‐2 cells. Notably, Smg treatment significantly increases the mRNA expression of KLB through the activation of the cyclic adenosine monophosphate (cAMP) signaling pathway, specifically through the phosphorylation of protein kinase A (PKA) and cAMP‐response element‐binding protein (CREB). Subsequently, the adenosine monophosphate‐activated protein kinase (AMPK) signaling pathway is activated, reprograming the key metabolic processes of ferroptosis such as iron metabolism, fatty acid synthesis, and the antioxidant response against lipid peroxidation. Suppression of ferroptosis by Smg further attenuates renal inflammation and fibrosis. This work highlights the potential of GLP‐1RAs and KLB targeting as promising therapeutic approaches for DKD management.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Chronic Kidney Disease and Diabetes · Parathyroid Disorders and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NHC Key Laboratory of Hormones and Development, Chu Hsien‐I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Key Laboratory of Metabolic Diseases Tianjin Medical University Tianjin 300134 China

Department of Nephrology The Fifth Hospital of Shanxi Medical University (Shanxi Provincial People's Hospital) Taiyuan Shanxi 030000 China

School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, Faculty of Medicine Tianjin University Tianjin 300072 China

School of Life Sciences Peking University Beijing 100871 China

Department of Internal Medicine Mayo Clinic Rochester MN 55901 USA

Nephropathy & Blood Purification Department The Second Hospital of Tianjin Medical University Tianjin 300134 China

Funding

China International Medical Foundation

References (100+)

Show source-provided references
1. 10.1016/j.diabres.2021.10911910.1016/j.diabres.2021.109119 ↗
2. 10.1111/dom.1400710.1111/dom.14007 ↗
3. 10.1038/nrneph.2015.17310.1038/nrneph.2015.173 ↗
4. 10.1038/s42255-020-00327-x10.1038/s42255-020-00327-x ↗
5. 10.1016/j.ajpc.2023.10050210.1016/j.ajpc.2023.100502 ↗
6. 10.1186/s12933-023-01793-910.1186/s12933-023-01793-9 ↗
7. Hocher B. · Nat. Rev. Nephrol. · 2017 · 13 · 12
8. 10.1038/s41419-021-03452-x10.1038/s41419-021-03452-x ↗
9. 10.1016/j.cell.2022.06.00310.1016/j.cell.2022.06.003 ↗
10. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
11. 10.1146/annurev-cancerbio-030518-05584410.1146/annurev-cancerbio-030518-055844 ↗
12. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
13. 10.1016/j.cell.2017.11.04810.1016/j.cell.2017.11.048 ↗
14. 10.1038/s41586-019-1707-010.1038/s41586-019-1707-0 ↗
15. 10.1038/s41586-019-1705-210.1038/s41586-019-1705-2 ↗
16. 10.1038/s41586-021-03539-710.1038/s41586-021-03539-7 ↗
17. 10.1021/acscentsci.9b0106310.1021/acscentsci.9b01063 ↗
18. 10.1016/j.cell.2023.05.00310.1016/j.cell.2023.05.003 ↗
19. 10.1016/j.freeradbiomed.2020.10.32310.1016/j.freeradbiomed.2020.10.323 ↗
20. 10.1016/j.ejphar.2020.17357410.1016/j.ejphar.2020.173574 ↗
21. Chen X. · J. Exp. Med. · 2021 · 218 · 6
22. 10.1152/ajprenal.00184.201910.1152/ajprenal.00184.2019 ↗
23. 10.1007/s00011-022-01672-110.1007/s00011-022-01672-1 ↗
24. 10.3389/fimmu.2023.129431710.3389/fimmu.2023.1294317 ↗
25. 10.1038/s41467-022-31772-910.1038/s41467-022-31772-9 ↗
26. 10.1016/j.freeradbiomed.2020.10.32310.1016/j.freeradbiomed.2020.10.323 ↗
27. 10.1038/s41419-021-03452-x10.1038/s41419-021-03452-x ↗
28. 10.1007/s11154-021-09661-110.1007/s11154-021-09661-1 ↗
29. 10.1016/j.redox.2021.10213110.1016/j.redox.2021.102131 ↗
30. 10.1038/s42255-022-00572-210.1038/s42255-022-00572-2 ↗
31. 10.1038/nm.280710.1038/nm.2807 ↗
32. 10.1038/sigtrans.2017.2310.1038/sigtrans.2017.23 ↗
33. 10.1038/nrneph.2016.4810.1038/nrneph.2016.48 ↗
34. 10.1016/j.molmet.2018.03.01110.1016/j.molmet.2018.03.011 ↗
35. 10.1080/23723556.2019.169937510.1080/23723556.2019.1699375 ↗
36. 10.1158/1541-7786.MCR-19-069110.1158/1541-7786.MCR-19-0691 ↗
37. 10.1016/j.biosystems.2018.01.00210.1016/j.biosystems.2018.01.002 ↗
38. 10.1038/s41392-020-00326-010.1038/s41392-020-00326-0 ↗
39. 10.1016/j.chembiol.2015.11.01610.1016/j.chembiol.2015.11.016 ↗
40. 10.1021/acsnano.0c0076410.1021/acsnano.0c00764 ↗
41. 10.1038/s41589-019-0408-110.1038/s41589-019-0408-1 ↗
42. 10.1038/nchembio.223910.1038/nchembio.2239 ↗
43. 10.1038/nchembio.223810.1038/nchembio.2238 ↗
44. 10.1016/j.cell.2017.09.04410.1016/j.cell.2017.09.044 ↗
45. 10.1038/s41589-019-0408-110.1038/s41589-019-0408-1 ↗
46. 10.1038/s41589-022-01249-310.1038/s41589-022-01249-3 ↗
47. 10.1038/s41418-021-00859-z10.1038/s41418-021-00859-z ↗
48. 10.1083/jcb.20210504310.1083/jcb.202105043 ↗
49. 10.1016/j.molcel.2018.10.04210.1016/j.molcel.2018.10.042 ↗
50. Chen X. · Cell Death Differ. · 2021 · 28 · 10
51. 10.1038/s41419-020-2298-210.1038/s41419-020-2298-2 ↗
52. 10.1016/j.molcel.2018.10.04210.1016/j.molcel.2018.10.042 ↗
53. 10.1016/j.cotox.2017.11.00210.1016/j.cotox.2017.11.002 ↗
54. 10.1101/cshperspect.a01114810.1101/cshperspect.a011148 ↗
55. 10.1186/s12950-019-0225-z10.1186/s12950-019-0225-z ↗
56. 10.1007/s00592-021-01736-410.1007/s00592-021-01736-4 ↗
57. 10.1016/j.bbrc.2020.10.04010.1016/j.bbrc.2020.10.040 ↗
58. 10.1038/s41556-020-0461-810.1038/s41556-020-0461-8 ↗
59. 10.1080/23723556.2020.176124210.1080/23723556.2020.1761242 ↗
60. 10.1038/nrendo.2011.22510.1038/nrendo.2011.225 ↗
61. 10.1038/nature0781310.1038/nature07813 ↗
62. 10.1016/j.chembiol.2020.03.01110.1016/j.chembiol.2020.03.011 ↗
63. 10.1152/advan.00052.200610.1152/advan.00052.2006 ↗
64. 10.1016/j.diabet.2015.02.00210.1016/j.diabet.2015.02.002 ↗
65. 10.1097/MOL.0b013e328328d0a410.1097/MOL.0b013e328328d0a4 ↗
66. 10.1016/j.kint.2023.09.02910.1016/j.kint.2023.09.029 ↗
67. 10.1159/00051772310.1159/000517723 ↗
68. 10.1016/j.tcb.2022.03.01210.1016/j.tcb.2022.03.012 ↗
69. 10.1259/bjr.2019056210.1259/bjr.20190562 ↗
70. 10.1161/JAHA.122.02771210.1161/JAHA.122.027712 ↗
71. 10.1111/dom.1265110.1111/dom.12651 ↗
72. 10.1080/08830185.2021.201673910.1080/08830185.2021.2016739 ↗
73. 10.1038/s41420-022-00931-810.1038/s41420-022-00931-8 ↗
74. 10.3389/fendo.2021.62639010.3389/fendo.2021.626390 ↗
75. 10.7554/eLife.6860310.7554/eLife.68603 ↗
76. Song W. · Medicine (United States) · 2023 · 102
77. 10.1016/j.phrs.2018.03.00410.1016/j.phrs.2018.03.004 ↗
78. 10.1038/s42255-022-00572-210.1038/s42255-022-00572-2 ↗
79. 10.1681/ASN.200912131110.1681/ASN.2009121311 ↗
80. 10.1016/j.arr.2008.10.00210.1016/j.arr.2008.10.002 ↗
81. 10.1038/s41581-018-0078-310.1038/s41581-018-0078-3 ↗
82. 10.1007/s10157-012-0621-710.1007/s10157-012-0621-7 ↗
83. 10.1155/2015/87219310.1155/2015/872193 ↗
84. 10.1155/2022/132938010.1155/2022/1329380 ↗
85. 10.1074/jbc.M110.17403710.1074/jbc.M110.174037 ↗
86. 10.1681/ASN.201508088810.1681/ASN.2015080888 ↗
87. 10.1038/s41556-020-0565-110.1038/s41556-020-0565-1 ↗
88. 10.1681/ASN.201208086510.1681/ASN.2012080865 ↗
89. 10.1038/s41581-020-00343-w10.1038/s41581-020-00343-w ↗
90. 10.1080/15384101.2019.158049510.1080/15384101.2019.1580495 ↗
91. 10.1016/j.brainres.2021.14766810.1016/j.brainres.2021.147668 ↗
92. 10.1007/s00109-016-1477-110.1007/s00109-016-1477-1 ↗
93. 10.1038/s41581-022-00658-w10.1038/s41581-022-00658-w ↗
94. 10.1016/j.cca.2022.04.01110.1016/j.cca.2022.04.011 ↗
95. 10.1038/s41422-019-0164-510.1038/s41422-019-0164-5 ↗
96. 10.1038/nature1419110.1038/nature14191 ↗
97. 10.1016/j.chembiol.2020.03.01610.1016/j.chembiol.2020.03.016 ↗
98. 10.1016/j.chom.2018.06.01010.1016/j.chom.2018.06.010 ↗
99. 10.1016/j.cell.2021.06.02810.1016/j.cell.2021.06.028 ↗
100. 10.1016/j.chom.2018.05.00910.1016/j.chom.2018.05.009 ↗